Clinical Trial Update: Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Ferrum Lek (iron(III) hydroxide polymaltosate) to MALTOFER for mild to moderate iron deficiency anemia has completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferrum Lek (Iron(III) hydroxide polymaltosate)
• MALTOFER (Iron(II/III) complex)

Snippet

Sponsor: Sandoz | Conditions: Mild and Moderate Iron-deficiency Anaemia | Phase 3 | Status: COMPLETED | Results posted: 2021-07-12